v3.25.4
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jan. 31, 2026
Apr. 30, 2025
Current assets:    
Cash and cash equivalents $ 7,127 $ 9,785
Accounts receivable, net 12,067 11,204
Prepaid expenses and other current assets 991 1,369
Total current assets 20,185 22,358
Operating lease right-of-use assets, net 4,026 5,080
Property and equipment, net 3,705 4,375
Other long-term assets 196 196
Goodwill 335 335
Total assets 28,447 32,344
Current liabilities:    
Accounts payable 5,726 4,248
Accrued liabilities 3,346 2,556
Current portion of operating lease liabilities 1,529 1,471
Other current liability 78 135
Deferred revenue 9,998 15,443
Total current liabilities 20,677 23,853
Non-current operating lease liabilities 3,365 4,634
Other non-current liabilities 27 85
Total liabilities 24,069 28,572
Stockholders’ equity:    
Common stock, $.001 par value; 200,000,000 shares authorized; 14,007,159 and 13,897,503 shares issued; and 13,886,826 and 13,777,170 outstanding as of January 31, 2026 and April 30, 2025, respectively 14 14
Treasury stock, at cost (708) (708)
Additional paid-in capital 85,377 84,358
Accumulated deficit (80,400) (79,892)
Total stockholders’ equity attributable to Champions Oncology, Inc. 4,283 3,772
Noncontrolling interest 95 0
Total stockholders' equity 4,378 3,772
Total liabilities and stockholders’ equity $ 28,447 $ 32,344